These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
286 related articles for article (PubMed ID: 25929342)
1. Mixed tau and TDP-43 pathology in a patient with unclassifiable primary progressive aphasia. Flanagan EP; Duffy JR; Whitwell JL; Vemuri P; Dickson DW; Josephs KA Neurocase; 2016; 22(1):55-9. PubMed ID: 25929342 [TBL] [Abstract][Full Text] [Related]
2. Frontotemporal lobar degeneration proteinopathies have disparate microscopic patterns of white and grey matter pathology. Giannini LAA; Peterson C; Ohm D; Xie SX; McMillan CT; Raskovsky K; Massimo L; Suh E; Van Deerlin VM; Wolk DA; Trojanowski JQ; Lee EB; Grossman M; Irwin DJ Acta Neuropathol Commun; 2021 Feb; 9(1):30. PubMed ID: 33622418 [TBL] [Abstract][Full Text] [Related]
3. Prediction of pathology in primary progressive language and speech disorders. Deramecourt V; Lebert F; Debachy B; Mackowiak-Cordoliani MA; Bombois S; Kerdraon O; Buée L; Maurage CA; Pasquier F Neurology; 2010 Jan; 74(1):42-9. PubMed ID: 19940270 [TBL] [Abstract][Full Text] [Related]
4. Divergent patterns of TDP-43 and tau pathologies in primary progressive aphasia. Giannini LAA; Xie SX; McMillan CT; Liang M; Williams A; Jester C; Rascovsky K; Wolk DA; Ash S; Lee EB; Trojanowski JQ; Grossman M; Irwin DJ Ann Neurol; 2019 May; 85(5):630-643. PubMed ID: 30851133 [TBL] [Abstract][Full Text] [Related]
5. Asymmetry and heterogeneity of Alzheimer's and frontotemporal pathology in primary progressive aphasia. Mesulam MM; Weintraub S; Rogalski EJ; Wieneke C; Geula C; Bigio EH Brain; 2014 Apr; 137(Pt 4):1176-92. PubMed ID: 24574501 [TBL] [Abstract][Full Text] [Related]
6. Divergent Histopathological Networks of Frontotemporal Degeneration Proteinopathy Subytpes. Chen M; Ohm DT; Phillips JS; McMillan CT; Capp N; Peterson C; Xie E; Wolk DA; Trojanowski JQ; Lee EB; Gee J; Grossman M; Irwin DJ J Neurosci; 2022 May; 42(18):3868-3877. PubMed ID: 35318284 [TBL] [Abstract][Full Text] [Related]
7. Concurrent tau pathologies in frontotemporal lobar degeneration with TDP-43 pathology. Koga S; Zhou X; Murakami A; Fernandez De Castro C; Baker MC; Rademakers R; Dickson DW Neuropathol Appl Neurobiol; 2022 Feb; 48(2):e12778. PubMed ID: 34823271 [TBL] [Abstract][Full Text] [Related]
8. Typical and atypical pathology in primary progressive aphasia variants. Spinelli EG; Mandelli ML; Miller ZA; Santos-Santos MA; Wilson SM; Agosta F; Grinberg LT; Huang EJ; Trojanowski JQ; Meyer M; Henry ML; Comi G; Rabinovici G; Rosen HJ; Filippi M; Miller BL; Seeley WW; Gorno-Tempini ML Ann Neurol; 2017 Mar; 81(3):430-443. PubMed ID: 28133816 [TBL] [Abstract][Full Text] [Related]
10. Ante mortem cerebrospinal fluid tau levels correlate with postmortem tau pathology in frontotemporal lobar degeneration. Irwin DJ; Lleó A; Xie SX; McMillan CT; Wolk DA; Lee EB; Van Deerlin VM; Shaw LM; Trojanowski JQ; Grossman M Ann Neurol; 2017 Aug; 82(2):247-258. PubMed ID: 28719018 [TBL] [Abstract][Full Text] [Related]
11. TDP-43 pathology in primary progressive aphasia and frontotemporal dementia with pathologic Alzheimer disease. Bigio EH; Mishra M; Hatanpaa KJ; White CL; Johnson N; Rademaker A; Weitner BB; Deng HX; Dubner SD; Weintraub S; Mesulam M Acta Neuropathol; 2010 Jul; 120(1):43-54. PubMed ID: 20361198 [TBL] [Abstract][Full Text] [Related]
12. In vivo signatures of nonfluent/agrammatic primary progressive aphasia caused by FTLD pathology. Caso F; Mandelli ML; Henry M; Gesierich B; Bettcher BM; Ogar J; Filippi M; Comi G; Magnani G; Sidhu M; Trojanowski JQ; Huang EJ; Grinberg LT; Miller BL; Dronkers N; Seeley WW; Gorno-Tempini ML Neurology; 2014 Jan; 82(3):239-47. PubMed ID: 24353332 [TBL] [Abstract][Full Text] [Related]
13. Mixed TDP-43 proteinopathy and tauopathy in frontotemporal lobar degeneration: nine case series. Kim EJ; Brown JA; Deng J; Hwang JL; Spina S; Miller ZA; DeMay MG; Valcour V; Karydas A; Ramos EM; Coppola G; Miller BL; Rosen HJ; Seeley WW; Grinberg LT J Neurol; 2018 Dec; 265(12):2960-2971. PubMed ID: 30324308 [TBL] [Abstract][Full Text] [Related]
14. TDP-43 Proteinopathy and Tauopathy: Do They Have Pathomechanistic Links? Riku Y; Yoshida M; Iwasaki Y; Sobue G; Katsuno M; Ishigaki S Int J Mol Sci; 2022 Dec; 23(24):. PubMed ID: 36555399 [TBL] [Abstract][Full Text] [Related]
15. Atrophy and microglial distribution in primary progressive aphasia with transactive response DNA-binding protein-43 kDa. Kim G; Bolbolan K; Gefen T; Weintraub S; Bigio EH; Rogalski E; Mesulam MM; Geula C Ann Neurol; 2018 Jun; 83(6):1096-1104. PubMed ID: 29665116 [TBL] [Abstract][Full Text] [Related]
16. Primary progressive aphasia as the initial manifestation of corticobasal degeneration and unusual tauopathies. Ferrer I; Hernández I; Boada M; Llorente A; Rey MJ; Cardozo A; Ezquerra M; Puig B Acta Neuropathol; 2003 Nov; 106(5):419-35. PubMed ID: 12955398 [TBL] [Abstract][Full Text] [Related]
17. Atypical TDP-43 proteinopathy clinically presenting with progressive nonfluent aphasia: A case report. Suzuki Y; Adachi T; Yoshida K; Taneda K; Sakuwa M; Hasegawa M; Hanajima R Neuropathology; 2024 Apr; 44(2):154-160. PubMed ID: 37717977 [TBL] [Abstract][Full Text] [Related]
18. The hippocampal longitudinal axis-relevance for underlying tau and TDP-43 pathology. Lladó A; Tort-Merino A; Sánchez-Valle R; Falgàs N; Balasa M; Bosch B; Castellví M; Olives J; Antonell A; Hornberger M Neurobiol Aging; 2018 Oct; 70():1-9. PubMed ID: 29935415 [TBL] [Abstract][Full Text] [Related]